Evotec SE (ETR:EVT)
6.51
+0.08 (1.24%)
Aug 14, 2025, 5:35 PM CET
Evotec SE Revenue
Evotec SE had revenue of 171.24M EUR in the quarter ending June 30, 2025, a decrease of -5.98%. This brings the company's revenue in the last twelve months to 777.33M, down -1.41% year-over-year. In the year 2024, Evotec SE had annual revenue of 796.97M with 1.99% growth.
Revenue (ttm)
777.33M
Revenue Growth
-1.41%
P/S Ratio
1.47
Revenue / Employee
163.34K
Employees
4,740
Market Cap
1.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Sartorius Aktiengesellschaft | 3.47B |
Fresenius Medical Care AG | 19.52B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.18B |
Evotec SE News
- 1 day ago - Evotec SE (EVO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Evotec SE 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 1 day ago - Evotec SE reports 1H results - Seeking Alpha
- 1 day ago - Earnings Scheduled For August 13, 2025 - Benzinga
- 1 day ago - Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution - Wallstreet:Online
- 1 day ago - Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution - Accesswire
- 1 day ago - Evotec SE's H1 2025 Results: Strategy Execution Shines Brightly - Wallstreet:Online
- 1 day ago - EQS-News: Evotec SE reports H1 2025 results: Strong progress on strategy execution - Wallstreet:Online